Synapse - Works

Results (5608)

A phase 1/2 study of CB-839, a first-in-class glutaminase inhibitor, combined with nivolumab in patients with advanced melanoma (MEL), renal cell carcinoma (RCC), or non-small cell lung cancer (NSCLC)

Meeting Abstract

Meric-Bernstam, F.; Gordon, M.; Tykodi, S.; Lam, E.; Vaishampayan, U.; Chaves, J.; Nikolinakos, P.; Fan, A.; Lee, R.; McDermott, D.; more...
Journal for ImmunoTherapy of Cancer (2017)

Fulltext@MSK | Save

Single arm phase I/II study of everolimus and intravesical gemcitabine in patients with primary or secondary carcinoma in situ of the bladder who failed bacillus Calmette Guerin (NCT01259063)

Journal Article

Dalbagni, G.; Benfante, N.; Sjoberg, D. D.; Bochner, B. H.; Donat, S. M.; Herr, H. W.; McCoy, A. S.; Fahrner, A. J.; Retinger, C.; Rosenberg, J. E.; more...
Bladder Cancer (2017)

Fulltext@MSK | Save

Population-scale identification of clonal hematopoiesis derived mutations in solid tumor mutation profiling

Meeting Abstract

Ptashkin, R.; Coombs, C. C.; Hyman, D. M.; Solit, D.; Baselga, J.; Arcila, M. E.; Ladanyi, M.; Levine, R. L.; Berger, M. F.; Zehir, A.
Blood (2017)

Fulltext@MSK | Save

Observational longitudinal study of pain in men with metastatic castrate-resistant prostate cancer: Aim 1. Rates of pain palliation and pain progression as indicated by self-reported daily pain and analgesic use

Meeting Abstract

Bennett, A. V.; Shouery, M.; Wang, M.; Whang, Y. E.; Milowsky, M.; Drier, S.; Carr, P.; Graff, J. N.; Morris, M. J.; Scher, H. I.; more...
Quality of Life Research (2017)

Fulltext@MSK | Save

Tumor xenografts of human clear cell renal cell carcinoma but not corresponding cell lines recapitulate clinical response to sunitinib: Feasibility of using biopsy samples

Journal Article

Dong, Y.; Manley, B. J.; Becerra, M. F.; Redzematovic, A.; Casuscelli, J.; Tennenbaum, D. M.; Reznik, E.; Han, S.; Benfante, N.; Chen, Y. B.; more...
European Urology Focus (2017)

Fulltext@MSK | Save

Effective prostate-specific membrane antigen-based (18)F-DCFPyL-guided cryoablation of a single positive site in a patient believed to be more metastatic on (11)C-choline PET/CT

Journal Article

Cornelis, F. H.; Durack, J. C.; Morris, M. J.; Scher, H. I.; Solomon, S. B.
Clinical Nuclear Medicine (2017)

Fulltext@MSK | Save

Keynote-045: Open-label, phase 3 study of pembrolizumab versus investigator's choice of paclitaxel, docetaxel, or vinflunine for previously treated advanced urothelial cancer

Meeting Abstract

Quinn, D.; Bellmunt, J.; de Wit, R.; Vaughn, D. J.; Fradet, Y.; Lee, J. L.; Fong, L.; Vogelzang, N. J.; Climent, M. A.; Petrylak, D. P.; more...
Asia-Pacific Journal of Clinical Oncology (2017)

Fulltext@MSK | Save

Trial of rucaparib in prostate indications 2 (TRITON2): An international, multicentre, open-label phase 2 study of the PARP inhibitor rucaparib in patients with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination deficiency (HRD)

Meeting Abstract

Shapiro, J.; Voskoboynik, M.; Krieger, L.; Byard, I.; Clay, T.; Ganju, V.; Abida, W.; Chowdhury, S.; Watkins, S.; Despain, D.; more...
Asia-Pacific Journal of Clinical Oncology (2017)

Fulltext@MSK | Save

Health-related quality of life (HRQoL) of pembrolizumab vs chemotherapy for previously treated advanced urothelial cancer (UC) in KEYNOTE-045

Meeting Abstract

Quinn, D.; Vaughn, D. J.; Bellmunt, J.; de Wit, R.; Fradet, Y.; Lee, J. L.; Fong, L.; Vogelzang, N. J.; Climent, M. A.; Petrylak, D. P.; more...
Asia-Pacific Journal of Clinical Oncology (2017)

Fulltext@MSK | Save

Does neoadjuvant androgen deprivation therapy impact erectile function recovery post-radical prostatectomy?

Meeting Abstract

Jenkins, L.; Touijer, K.; Rathkopf, D.; Nelson, C.; Mulhall, J.
Journal of Sexual Medicine (2017)

Fulltext@MSK | Save